Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Efficiency of Extracellular Vesicles (EVs) from Stem Cell Sources in hypoxic retinal muller cells
Author Affiliations & Notes
  • mahek anand
    University of Illinois Chicago, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   mahek anand None
  • Footnotes
    Support  NIH P30 EY001792
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1258. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      mahek anand; Efficiency of Extracellular Vesicles (EVs) from Stem Cell Sources in hypoxic retinal muller cells. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1258.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal ischemia is a leading cause of vision impairment and retinal degeneration, resulting from insufficient oxygen supply to the retina. Mesenchymal-derived (MSC) extracellular vesicles (EVs) have emerged as a potential therapeutic intervention to rescue retinal cells from apoptotic injury. In this study, we exposed Müller cells to hypoxic conditions to simulate ischemic -like conditions. We evaluated the neuroprotective effects of EVs derived from two diverse sources of MSCs - bone marrow and dental pulp cells - in an in vitro Müller cell-based hypoxic model.

Methods : Müller cells were subjected to hypoxia for 10 hours or 18 hours, followed by exposure to normoxic oxygen levels for 18 hours and 12 hours, respectively. MSC-derived EVs from bone marrow and dental pulp were isolated through precipitation and centrifugation, with size and concentration determined using Nanoparticle Tracking Analysis. After hypoxic exposure, a concentration of 2 * 107 MSC and DPSC EVs were added independently to the cells, and their neuroprotective effects were quantitatively assessed through MTS assays for cell viability and ROS assay. Qualitative evaluations were performed through immunofluorescence

Results : Results
Both DPSC EVs and MSC EVs demonstrated neuroprotective effect. The Müller cells subjected to hypoxia showed a significant decrease in viability compared to control Müller cells (0.5 vs 1.6, absorbance < 0.0001). However, a significant improvement was observed in both DPSC EVs and MSC EVs (0.5vs1.5, absorbance,p <0.0001). Similarly, the hypoxia induced ROS was significantly decreased in hypoxic Müller cells receiving EV’s compared to hypoxic Müller cells receiving PBS alone (2000 vs 3500 fluorescence intensity, p<0.0001). Immunostaining analysis showed an increased KI67 expression and profuse vimentin cytoplasmic staining in control Müller cells with distorted vimentin and KI67 staining in hypoxic cells. Hypoxic cells treated with EVs showed an improved KI67 staining in nucleus and vimentin staining in cytoplasm.

Conclusions : The cell viability and immunostaining show the neuroprotective effect of EVs and supports the hypothesis for successful rescue of Müller cells from cell death. However, further studies are needed to account for mechanism of EV rescue.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×